Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma (Q39517040)

12 September 2017

Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma (English)

1 reference

12 September 2017

1 reference

1 reference

7

Bostwick DG

1 reference

12 September 2017

Gettman MT

1

1 reference

12 September 2017

Pacelli A

2

1 reference

12 September 2017

Slezak J

3

1 reference

12 September 2017

Bergstralh EJ

4

1 reference

12 September 2017

Blute M

5

1 reference

12 September 2017

Zincke H

6

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 September 1999

1 reference

12 September 2017

1 reference

12 September 2017

54

1 reference

12 September 2017

3

1 reference

12 September 2017

479-485

1 reference

Bilateral pelvic lymphadenectomy and radical prostatectomy for clinical stage C prostatic cancer: role of adjuvant treatment for residual cancer and in disease progression

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900202-2

7 January 2021

Extended experience with radical prostatectomy for clinical stage T3 prostate cancer: outcome and contemporary morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900202-2

7 January 2021

Impact of radical prostatectomy in the management of clinically localized disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900202-2

7 January 2021

Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900202-2

7 January 2021

Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900202-2

7 January 2021

Radical prostatectomy for pathologic stage C prostate cancer: influence of pathologic variables and adjuvant treatment on disease outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900202-2

7 January 2021

Influence of DNA ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (PT3) prostate cancer after radical retropubic prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900202-2

7 January 2021

Radical prostatectomy for adenocarcinoma of the prostate: the influence of preoperative and pathologic findings on biochemical disease-free outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900202-2

7 January 2021

Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate: impact of adjuvant treatment (hormonal and radiation)

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900202-2

7 January 2021

Adenocarcinoma of the prostate invading the seminal vesicle: definition and relation of tumor volume, grade and margins of resection to prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900202-2

7 January 2021

Pathologic classification of prostate carcinoma: the impact of margin status

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900202-2

7 January 2021

Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900202-2

7 January 2021

Quantitative microvessel density. A staging and prognostic marker for human prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900202-2

7 January 2021

Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900202-2

7 January 2021

Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900202-2

7 January 2021

Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900202-2

7 January 2021

Prediction of patient outcome in pathologic stage T2 adenocarcinoma of the prostate: lack of significance for microvessel density analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900202-2

7 January 2021

Staging and reporting of prostate cancer--sampling of the radical prostatectomy specimen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900202-2

7 January 2021

Pathologic staging of prostate carcinoma. What are the issues?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900202-2

7 January 2021

Staging of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900202-2

7 January 2021

Measurement of serum prostate specific antigen using IMx prostate specific antigen assay

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900202-2

7 January 2021

10.1016/S0090-4295(99)00202-2

Identifiers

DOI

1 reference

12 September 2017

1 reference